AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 159 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 9.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $17,000 | +41.7% | 948 | +5.0% | 0.00% | 0.0% |
| Q4 2020 | $12,000 | -45.5% | 903 | -50.8% | 0.00% | -50.0% |
| Q3 2020 | $22,000 | -56.9% | 1,835 | -46.5% | 0.00% | -66.7% |
| Q2 2020 | $51,000 | +750.0% | 3,432 | +1220.0% | 0.01% | +500.0% |
| Q4 2019 | $6,000 | +500.0% | 260 | +766.7% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 30 | +76.5% | 0.00% | – |
| Q2 2018 | $1,000 | -90.9% | 17 | -92.6% | 0.00% | -100.0% |
| Q3 2017 | $11,000 | -52.2% | 230 | -53.8% | 0.01% | -73.3% |
| Q1 2017 | $23,000 | – | 498 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |